154 related articles for article (PubMed ID: 28654152)
1. Race-specific molecular alterations correlate with differential outcomes for black and white endometrioid endometrial cancer patients.
Bateman NW; Dubil EA; Wang G; Hood BL; Oliver JM; Litzi TA; Gist GD; Mitchell DA; Blanton B; Phippen NT; Tian C; Zahn CM; Cohn DE; Havrilesky LJ; Berchuck A; Shriver CD; Darcy KM; Hamilton CA; Conrads TP; Maxwell GL
Cancer; 2017 Oct; 123(20):4004-4012. PubMed ID: 28654152
[TBL] [Abstract][Full Text] [Related]
2. Racial disparities in molecular subtypes of endometrial cancer.
Dubil EA; Tian C; Wang G; Tarney CM; Bateman NW; Levine DA; Conrads TP; Hamilton CA; Maxwell GL; Darcy KM
Gynecol Oncol; 2018 Apr; 149(1):106-116. PubMed ID: 29605044
[TBL] [Abstract][Full Text] [Related]
3. Racial disparities in young women with endometrial cancer.
Mukerji B; Baptiste C; Chen L; Tergas AI; Hou JY; Ananth CV; Neugut AI; Hershman DL; Wright JD
Gynecol Oncol; 2018 Mar; 148(3):527-534. PubMed ID: 29307452
[TBL] [Abstract][Full Text] [Related]
4. The association of black race with receipt of hysterectomy and survival in low-risk endometrial cancer.
Taylor KN; Li A; Manuel M; Rimel BJ; Kim KH
Gynecol Oncol; 2023 Aug; 175():156-162. PubMed ID: 37390596
[TBL] [Abstract][Full Text] [Related]
5. The influence of comorbid conditions on racial disparities in endometrial cancer survival.
Ruterbusch JJ; Ali-Fehmi R; Olson SH; Sealy-Jefferson S; Rybicki BA; Hensley-Alford S; Elshaikh MA; Gaba AR; Schultz D; Munkarah AR; Cote ML
Am J Obstet Gynecol; 2014 Dec; 211(6):627.e1-9. PubMed ID: 24954655
[TBL] [Abstract][Full Text] [Related]
6. Black and Hispanic women are less likely than white women to receive guideline-concordant endometrial cancer treatment.
Kaspers M; Llamocca E; Quick A; Dholakia J; Salani R; Felix AS
Am J Obstet Gynecol; 2020 Sep; 223(3):398.e1-398.e18. PubMed ID: 32142825
[TBL] [Abstract][Full Text] [Related]
7. A GOG 210 aCGH study of gain at 1q23 in endometrioid endometrial cancer in the context of racial disparity and outcome.
Morrison C; Miecznikowski J; Darcy KM; Dolce JM; Kandel E; Erwin DO; Liu S; Shepherd L; Cohn D; McMeekin DS; Block AW; Nowak NJ; Maxwell L
Genes Chromosomes Cancer; 2010 Sep; 49(9):791-802. PubMed ID: 20607851
[TBL] [Abstract][Full Text] [Related]
8. The Growing Burden of Endometrial Cancer: A Major Racial Disparity Affecting Black Women.
Cote ML; Ruterbusch JJ; Olson SH; Lu K; Ali-Fehmi R
Cancer Epidemiol Biomarkers Prev; 2015 Sep; 24(9):1407-15. PubMed ID: 26290568
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of CTNNB1 mutation and Wnt pathway activation in endometrioid endometrial carcinoma.
Liu Y; Patel L; Mills GB; Lu KH; Sood AK; Ding L; Kucherlapati R; Mardis ER; Levine DA; Shmulevich I; Broaddus RR; Zhang W
J Natl Cancer Inst; 2014 Sep; 106(9):. PubMed ID: 25214561
[TBL] [Abstract][Full Text] [Related]
10. Prognostic factors for tumor recurrence in endometrioid endometrial cancer stages IA and IB.
Han KH; Kim HS; Lee M; Chung HH; Song YS
Medicine (Baltimore); 2017 May; 96(21):e6976. PubMed ID: 28538399
[TBL] [Abstract][Full Text] [Related]
11. Cyr61, a member of ccn (connective tissue growth factor/cysteine-rich 61/nephroblastoma overexpressed) family, predicts survival of patients with endometrial cancer of endometrioid subtype.
Watari H; Xiong Y; Hassan MK; Sakuragi N
Gynecol Oncol; 2009 Jan; 112(1):229-34. PubMed ID: 19007976
[TBL] [Abstract][Full Text] [Related]
12. Endometrial cancer in morbidly obese women: do racial disparities affect surgical or survival outcomes?
Cote ML; Ruterbusch JJ; Ahmed Q; Bandyopadhyay S; Alosh B; Abdulfatah E; Seward S; Morris R; Ali-Fehmi R
Gynecol Oncol; 2014 Apr; 133(1):38-42. PubMed ID: 24680590
[TBL] [Abstract][Full Text] [Related]
13. Expression Patterns of the Wnt Pathway Inhibitors Dickkopf3 and Secreted Frizzled-Related Proteins 1 and 4 in Endometrial Endometrioid Adenocarcinoma: An NRG Oncology/Gynecologic Oncology Group Study.
Eskander RN; Ali S; Dellinger T; Lankes HA; Randall LM; Ramirez NC; Monk BJ; Walker JL; Eisenhauer E; Hoang BH
Int J Gynecol Cancer; 2016 Jan; 26(1):125-32. PubMed ID: 26397159
[TBL] [Abstract][Full Text] [Related]
14. Integrative Protein-Based Prognostic Model for Early-Stage Endometrioid Endometrial Cancer.
Yang JY; Werner HM; Li J; Westin SN; Lu Y; Halle MK; Trovik J; Salvesen HB; Mills GB; Liang H
Clin Cancer Res; 2016 Jan; 22(2):513-23. PubMed ID: 26224872
[TBL] [Abstract][Full Text] [Related]
15. Endometrial carcinoma recurrence according to race and ethnicity: An NRG Oncology/Gynecologic Oncology Group 210 Study.
Felix AS; Brasky TM; Cohn DE; Mutch DG; Creasman WT; Thaker PH; Walker JL; Moore RG; Lele SB; Guntupalli SR; Downs LS; Nagel C; Boggess JF; Pearl ML; Ioffe OB; Deng W; Miller DS; Brinton LA
Int J Cancer; 2018 Mar; 142(6):1102-1115. PubMed ID: 29063589
[TBL] [Abstract][Full Text] [Related]
16. Disparities in receipt of care for high-grade endometrial cancer: A National Cancer Data Base analysis.
Bregar AJ; Alejandro Rauh-Hain J; Spencer R; Clemmer JT; Schorge JO; Rice LW; Del Carmen MG
Gynecol Oncol; 2017 Apr; 145(1):114-121. PubMed ID: 28159409
[TBL] [Abstract][Full Text] [Related]
17. DNMT3A/3B overexpression might be correlated with poor patient survival, hypermethylation and low expression of ESR1/PGR in endometrioid carcinoma: an analysis of The Cancer Genome Atlas.
He D; Wang X; Zhang Y; Zhao J; Han R; Dong Y
Chin Med J (Engl); 2019 Jan; 132(2):161-170. PubMed ID: 30614867
[TBL] [Abstract][Full Text] [Related]
18. Impact of hospital volume on racial disparities and outcomes for endometrial cancer.
Buskwofie A; Huang Y; Tergas AI; Hou JY; Ananth CV; Neugut AI; Hershman DL; Wright JD
Gynecol Oncol; 2018 May; 149(2):329-336. PubMed ID: 29506862
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathologic characteristics and outcomes of endometrial Cancer patients with mismatch repair deficiency in the era of universal Lynch syndrome screening.
Carr C; Son J; Yao M; Priyadarshini A; Marquard J; Vargas R; Michener C; AlHilli MM
Gynecol Oncol; 2020 Dec; 159(3):712-720. PubMed ID: 33046272
[TBL] [Abstract][Full Text] [Related]
20. MicroRNAs in endometrial cancers from black and white patients.
Maxwell GL; Shoji Y; Darcy K; Litzi T; Berchuck A; Hamilton CA; Conrads TP; Risinger JI
Am J Obstet Gynecol; 2015 Feb; 212(2):191.e1-10. PubMed ID: 25174797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
